26th May 2026
CRF is Happening on
23
Hours
27
Minutes
07
Seconds
CRF is Happening on
15th May 2026
CRF is Happening on
15th May 2026
The Forum for Forward Thinkers in
Haemato-Oncology
The Clinical Research Forum 2026 is the premier global platform uniting leading Key Opinion Leaders (KOLs), clinical researchers, and industry innovators at the forefront of blood cancer research and treatment. This high-level, strategy-focused forum is designed to foster scientific exchange, uncover breakthrough insights, and shape the future of haemato-oncology care.
Taking place in May 2026, the Forum offers an exclusive environment for in-depth discussions on emerging therapies, trial innovations, patient-centric strategies, and regulatory trends. With a curated agenda and influential attendees from across academia, biotech, and pharma, this is a must-attend event for organisations seeking to align with thought leaders and drive impactful partnerships in the haemato-oncology space.
Join us at the intersection of science, strategy, and collaboration, where innovation meets influence.
Unmatched Expertise
Hear directly from leading clinicians, researchers, and policy influencers shaping the haemato-oncology landscape.
Strategic Foresight
Gain early insight into emerging treatments, trial methodologies, health economics, and market dynamics.
Collaboration at Scale
Network with decision-makers across pharma, biotech, diagnostics, and academic medicine in a purpose-built, non-promotional environment.
Unmatched Expertise
Hear directly from leading clinicians, researchers, and policy influencers shaping the haemato-oncology landscape.
Collaboration at Scale
Network with decision-makers across pharma, biotech, diagnostics, and academic medicine in a purpose-built, non-promotional environment.
Strategic Foresight
Gain early insight into emerging treatments, trial methodologies, health economics, and market dynamics.
CRF26 is where the future of haemato-oncology takes shape, uniting global leaders in research, strategy, and innovation.
CRF26 in Numbers
200+
Clinicians in Attendance
100+
NHS Executives
50+
Partners
40+
Expert Speakers
20+
Healthcare Partners
200+
Clinicians in Attendance
100+
NHS Executives
50+
Partners
20+
Patient Organisations
20+
Healthcare Partners
Our Key-Note Speakers and Clinical Contributors
Dr Sue Pavord
President, British Society for Haematology | Director, Oxford Iron Clinic
Dr Sue Pavord
President, British Society for Haematology | Director, Oxford Iron Clinic
Dr Sue Pavord
President, British Society for Haematology | Director, Oxford Iron Clinic
Dr Sue Pavord
President, British Society for Haematology | Director, Oxford Iron Clinic
Our Key-Note Speakers and Clinical Contributors
Professor Claire Harrison
Deputy Chief Medical Officer, Guys and St Thomas’ NHS Foundation Trust
Orlando Agrippa
Chief Executive Officer,
Sanius Health
Professor Sue
Pavord
President, British Society for Haematology and Consultant Haematologist, Oxford University Hospitals NHS Foundation Trust
Professor Charles Craddock
Academic Director Centre for Clinical Haematology, University Hospitals Birmingham
David Probert
Chief Executive Officer, University College Hospitals London and Deputy Chief Executive Officer, NHS England.
Dr. Emma Searle
Consultant Haematologist- Early Phase Trials, The Christie | Honorary Senior Lecturer, University of Manchester
Dame Lesley Fallowfield DBE
Professor of Psycho-oncology, Brighton and Sussex Medical School
Dr Sanne Lugthart
Consultant Haematologist, University Hospitals Bristol NHS FT
Eric Low OBE
Eric Low Consulting
Our Previous Keynote Speakers
and Clinical Contributors
Professor Sue Pavord
President, British Society for Haematology and Consultant Haematologist, Oxford University Hospitals NHS Foundation Trust
Sir James Mackey
Chief Executive of NHS England
Professor Claire Harrison
Deputy Chief Medical Officer, Guys and St Thomas’ NHS Foundation Trust
David Probert
Chief Executive Officer, University College Hospitals London and Deputy Chief Executive Officer, NHS England.
Professor Shirley D'sa MD, FRCP, FRCPath
Consultant Haematologist & Clinical Lead | Honorary Associate Professor at the UCL Cancer Institute | University College London Hospitals NHS Foundation Trust
Dame Lesley Fallowfield DBE
Director of Psychosocial Oncology at University of Sussex
Dr Sanne Lugthart
Consultant Haematologist, University Hospitals Bristol NHS Foundation Trust
Professor Ashutosh Wechalekar
Senior lecturer and Consultant Haematologist | UCLH & the Royal Free London NHS FT
Our Previous
Keynote Speakers
and Clinical Contributors
Professor Sue Pavord
President, British Society for Haematology and Consultant Haematologist, Oxford University Hospitals NHS Foundation Trust
Sir James Mackey
Chief Executive of NHS England
Professor Claire Harrison
Deputy Chief Medical Officer, Guys and St Thomas’ NHS Foundation Trust
David Probert
Chief Executive Officer, University College Hospitals London and Deputy Chief Executive Officer, NHS England.
Professor Shirley D'sa MD, FRCP, FRCPath
Consultant Haematologist & Clinical Lead | Honorary Associate Professor at the UCL Cancer Institute | University College London Hospitals NHS Foundation Trust
Dame Lesley Fallowfield DBE
Director of Psychosocial Oncology at University of Sussex
Dr Sanne Lugthart
Consultant Haematologist, University Hospitals Bristol NHS Foundation Trust
Professor Ashutosh Wechalekar
Senior lecturer and Consultant Haematologist | UCLH & the Royal Free London NHS FT
Meet Industry Leaders
Deputy Chief Medical Officer, Guys and St Thomas’ NHS Foundation Trust
Claire Harrison
Chief Executive Officer, University College Hospitals London and Deputy Chief Executive Officer, NHS England.
David Probert
Chief Medical Officer,
Heidi Health
Hannah Allen
CEO of Modality Partnership
Vincent Sai
Chief Executive Officer,
Sanius Health
Orlando Agrippa
Agenda & Flow of the Day
11:40
Three-Course Networking Lunch with Haem-Onc Colleagues
Location: Networking Lounge & Dining Area
13:00
Precision Medicine in Oncology: Innovations in Molecular Targeting
13:30
Targeted Advances in Myelofibrosis: A focused session exploring the evolving landscape of MF treatments and diagnostics. Sponsored Session
14:00
AI and Tech in Haemato-Oncology: Real-World Applications and Predictive Potential
14:30
Sponsored Spotlight: Leveraging Digital Biomarkers in Blood Cancer Trials
15:15
Haem-Onc Leadership: Addressing Workforce Resilience and Systemic Challenges
15:45
Sponsored Deep Dive: Novel Therapeutics and Trial Updates in Multiple Myeloma.
Sponsored by: Partner
16:15
Building Trust in Oncology Communication: Tools for Clinical Impact
16:30
Patient-Powered Innovation: Stories and Strategy With national patient ambassadors and care advocates
16:45
Parallel Workshop: Advanced Therapies in Practice – CAR-T, BiTEs, and More
Location: Breakout Room A
17:00
Panel Discussion: The Next Decade in Haem-Onc – Policy, Access, Innovation
Moderated by: Senior NHS Leaders
17:15
Closing Keynote: A Vision for Haem-Onc in 2035
12:00-17:30
Evening Reception: Clinical Community Mixer
Location: Garden Terrace I Drinks, canapés, and networking
12:00 – 17:30
Above is provisional and may be subject to change. Final schedule to be confirmed.
Agenda & Flow of the Day
This year’s programme takes place at Central Hall Westminster, an iconic Grade II venue overlooking Westminster Abbey. The CRF26 agenda blends expert panels, scientific deep dives, and high-level networking to drive real progress in haemato-oncology.
11:40
Three-Course Networking Lunch with Haem-Onc Colleagues
Location: Networking Lounge & Dining Area
13:00
Precision Medicine in Oncology: Innovations in Molecular Targeting
13:30
Targeted Advances in Myelofibrosis: A focused session exploring the evolving landscape of MF treatments and diagnostics. Sponsored Session
14:00
AI and Tech in
Haemato-Oncology: Real-World Applications and Predictive Potential
14:30
Sponsored Spotlight: Leveraging Digital Biomarkers in Blood Cancer Trials
15:15
Haem-Onc Leadership: Addressing Workforce Resilience and Systemic Challenges
15:45
Sponsored Deep Dive: Novel Therapeutics and Trial Updates in Multiple Myeloma
Sponsored by: Partner
16:15
Building Trust in Oncology Communication: Tools for Clinical Impact
16:30
Patient-Powered Innovation: Stories and Strategy
With national patient ambassadors and care advocates
16:45
Parallel Workshop: Advanced Therapies in Practice – CAR-T, BiTEs, and More
Location: Breakout Room A
17:00
Panel Discussion: The Next Decade in Haem-Onc – Policy, Access, Innovation
Moderated by: Senior NHS Leaders
17:15
Closing Keynote: A Vision for Haem-Onc in 2035
What you'll get access to
Unmatched Expertise
Hear directly from leading clinicians, researchers, and policy influencers shaping the haemato-oncology landscape.
Strategic Foresight
Gain early insight into emerging treatments, trial methodologies, health economics, and market dynamics.
Collaboration at Scale
Network with decision-makers across pharma, biotech, diagnostics, and academic medicine in a purpose-built, non-promotional environment.
Our Previous Sponsors Include
The KOL2025 was organised by Sanius Health and sponsored through funding by a number of pharmaceutical companies. These companies have had no involvement in the organisation, agenda or catering of this meeting, with the exception of the sponsored symposium sessions for which the sponsoring company is fully responsible.
Our Previous Sponsors
and Partners Include
The HPCC and KOL was organised by Sanius Health and sponsored through funding by a number of pharmaceutical companies. These companies have had no involvement in the organisation, agenda or catering of this meeting, with the exception of the sponsored symposium sessions for which the sponsoring company is fully responsible.
Our Previous Sponsors
and Partners Include
The HPCC and KOL was organised by Sanius Health and sponsored through funding by a number of pharmaceutical companies. These companies have had no involvement in the organisation, agenda or catering of this meeting, with the exception of the sponsored symposium sessions for which the sponsoring company is fully responsible.
Our Previous Sponsors Include
The KOL2025 was organised by Sanius Health and sponsored through funding by a number of pharmaceutical companies. These companies have had no involvement in the organisation, agenda or catering of this meeting, with the exception of the sponsored symposium sessions for which the sponsoring company is fully responsible.
The Clinical Research Forum 2026: Set in the Iconic Central Hall, Westminster, London
Set within the iconic Central Hall Westminster, a Grade II* listed venue in the heart of London with unrivalled views of Westminster Abbey, CRF26 promises a world-class platform for shaping the future of blood cancer research.
The Clinical Research Forum 2026: Set in the Iconic Central Hall, Westminster, London
Set within the iconic Central Hall Westminster,
a Grade II* listed venue in the heart of London with unrivalled views of Westminster Abbey, CRF26 promises a world-class platform for shaping the future of blood cancer research.
Our Previous Sponsors Include
The KOL2025 was organised by Sanius Health and sponsored through funding by a number of pharmaceutical companies. These companies have had no involvement in the organisation, agenda or catering of this meeting, with the exception of the sponsored symposium sessions for which the sponsoring company is fully responsible.
Our Previous Sponsors Include
The KOL2025 was organised by Sanius Health and sponsored through funding by a number of pharmaceutical companies. These companies have had no involvement in the organisation, agenda or catering of this meeting, with the exception of the sponsored symposium sessions for which the sponsoring company is fully responsible.
A Forum that Brings Voices from Across the System: Policy, Practice, and Research
Agenda & Flow of the Day
11:40
Three-Course Networking Lunch with Haem-Onc Colleagues
Location: Networking Lounge & Dining Area
13:00
Precision Medicine in Oncology: Innovations in Molecular Targeting
13:30
Targeted Advances in Myelofibrosis: A focused session exploring the evolving landscape of MF treatments and diagnostics. Sponsored Session
14:00
AI and Tech in Haemato-Oncology: Real-World Applications and Predictive Potential
14:30
Sponsored Spotlight: Leveraging Digital Biomarkers in Blood Cancer Trials
15:15
Haem-Onc Leadership: Addressing Workforce Resilience and Systemic Challenges
15:45
Sponsored Deep Dive: Novel Therapeutics and Trial Updates in Multiple Myeloma.
Sponsored by: Partner
16:15
Building Trust in Oncology Communication: Tools for Clinical Impact
16:30
Patient-Powered Innovation: Stories and Strategy With national patient ambassadors and care advocates
16:45
Parallel Workshop: Advanced Therapies in Practice – CAR-T, BiTEs, and More
Location: Breakout Room A
17:00
Panel Discussion: The Next Decade in Haem-Onc – Policy, Access, Innovation
Moderated by: Senior NHS Leaders
17:15
Closing Keynote: A Vision for Haem-Onc in 2035
12:00-17:30
Evening Reception: Clinical Community Mixer
Location: Garden Terrace I Drinks, canapés, and networking
12:00 – 17:30
Above is provisional and may be subject to change. Final schedule to be confirmed.
Strategy
CRF26 provides a strategic platform for pharmaceutical leaders and biotech innovators to explore new trial models, unlock pipeline opportunities, and shape the commercial roadmap for next-gen blood cancer therapies.
Execution
At CRF26, clinicians and academic researchers lead the conversation on trial innovation, patient stratification, and translating evidence into practice, driving better design, delivery, and decision-making in haemato-oncology.
Strategy
CRF26 provides a strategic platform for pharmaceutical leaders and biotech innovators to explore new trial models, unlock pipeline opportunities, and shape the commercial roadmap for next-gen blood cancer therapies.
Execution
At CRF26, clinicians and academic researchers lead the conversation on trial innovation, patient stratification, and translating evidence into practice, driving better design, delivery, and decision-making in haemato-oncology.
Unmatched Expertise
Hear directly from leading clinicians, researchers, and policy influencers shaping the haemato-oncology landscape.
Unmatched Expertise
Hear directly from leading clinicians, researchers, and policy influencers shaping the haemato-oncology landscape.
It’s all about a dialogue
A few words from our clients. See client stories for more.
Use this space to share a testimonial quote about the business, its products or its services. Insert a quote from a real customer or client here to build trust and win over site visitors.
Maria Goncavales, CFO
Laderate
Use this space to share a testimonial quote about the business, its products or its services. Insert a quote from a real customer or client here to build trust and win over site visitors.
Michael Soveign
Seven Energy
Use this space to share a testimonial quote about the business, its products or its services. Insert a quote from a real customer or client here to build trust and win over site visitors.
Jeffrey Cohen, CEO
Nato Productions
Industries
Infrastructure
Use this space to promote the business, its products or its services. Help people become familiar with the business and its offerings, creating a sense of connection and trust.
Technology
Use this space to promote the business, its products or its services. Help people become familiar with the business and its offerings, creating a sense of connection and trust.
50+
Partners